Project 1: Locating General Anesthetic Binding Sites in GABAA & Acetylcholine Rec
项目 1:定位 GABAA 中的全身麻醉结合位点
基本信息
- 批准号:7777109
- 负责人:
- 金额:$ 29.7万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2009
- 资助国家:美国
- 起止时间:2009-09-30 至 2014-08-31
- 项目状态:已结题
- 来源:
- 关键词:AcetylcholineAdverse effectsAffinityAgonistAlcoholsAmino AcidsAnestheticsBarbituratesBindingBinding SitesBrainCattleChemical StructureChemosensitizationCholinergic ReceptorsCollaborationsCultured CellsDetergentsDevelopmentDiazomethaneElectric OrganEtomidateFamilyGated Ion ChannelGeneral anesthetic drugsGoalsHumanInstructionIntravenous AnestheticsIon ChannelLabelLigandsLocationMapsMuscleNeuronsNeurotransmittersNicotinic ReceptorsPharmaceutical PreparationsPhotoaffinity LabelsPostsynaptic MembraneProductionPropofolProtein ChemistryProteinsRadiolabeledRecombinantsRestSiteSkeletal MuscleStructureSynapsesSynthesis ChemistryTechniquesTestingTimeTorpedoTransmembrane Domainanalogbarbituric acid saltdesigngamma-Aminobutyric Acidimprovedinhibitor/antagonistmembermutantnovelprogramsradiotracerreceptorthree dimensional structure
项目摘要
LOCATING GENERAL ANESTHETIC BINDING SITES IN GABAA AND ACETYLCHOLINE RECEPTORS
Our goal is to determine the number and location of the binding sites for general anesthetics in GABAARS, a
major site of action of a structurally diverse group of general anesthetics used clinically, and to compare
them with their binding sites in nicotinic acetylcholine receptors (AcChoRs), receptors that are both members
of the "Cys-loop" superfamily of neurotransmitter-gated ion channels. Most anesthetics potentiate the action
of GABA at the inhibitory GABAA receptors, while they inhibit the excitatory AcChoRs in brain and skeletal
muscle. Within a single receptor multiple potential anesthetic binding sites are present in the pockets that
exist within receptor subunits and at subunit interfaces, including the ion channel. It is our hypothesis that
each anesthetic, depending on structural class, will interact preferentially with different receptor sites. An
improved understanding of the diversity of general anesthetic binding sites within neurotransmitter-gated ion
channels will allow for the design of safer anesthetic agents. We propose to use photoaffinity labeling and
protein chemistry techniques to identify the binding sites for photoreactive aliphatic alcohols and analogs of
etomidate, propofol, and barbiturates in GABAARS isolated from detergent extracts of bovine brain and
cultured cells, in neuronal a4p2 AcChoRs isolated from cultured cells, and in muscle-type AcChoRs in
nicotinic postsynaptic membranes isolated from Torpedo electric organ. We will determine whether a single
anesthetic binding site in a GABAAR (or AcChoR) can be occupied by drugs that, depending on structure, act
as potentiators or inhibitors. These photoaffinity labeling studies make use of the Synthetic Chemistry,
Protein Chemistry and Protein Production Cores. Our structural studies are complementary to the time-
resolved photolabeling studies in (Miller/Raines Project) and to the mutational analyses (Forman Project)
designed to determine whether the sites we identify are sites of functional potentiation or inhibition.
RELEVANCE (See instructions):
GABAARS in the brain are a major site of action of many clinically used anesthetics of diverse chemical
structure, but the number and location of anesthetic binding sites within GABAARS or in the structurally
related nicotinic acetylcholine receptors remains unknown. Identification of these sites will contribute to the
development of anesthetics with greater selectivity and fewer side-effects.
GABAA和乙酰胆碱受体中全身麻醉药结合位点的定位
我们的目标是确定GABAARS中全身麻醉药结合位点的数量和位置,
临床上使用的一组结构不同的全身麻醉药的主要作用部位,并比较
它们与烟碱乙酰胆碱受体(AcChoR)的结合位点,这两种受体都是
神经递质门控离子通道的“半胱氨酸环”超家族。大多数麻醉剂都能增强这种作用
GABA的抑制性GABAA受体,而它们抑制大脑和骨骼肌中的兴奋性AcChoRs
肌肉.在单个受体内,多个潜在的麻醉剂结合位点存在于口袋中,
存在于受体亚单位内和亚单位界面,包括离子通道。我们假设
根据结构类别,每种麻醉剂将优先与不同的受体位点相互作用。一个
提高了对神经递质门控离子通道内全身麻醉剂结合位点多样性的认识
通道将允许设计更安全的麻醉剂。我们建议使用光亲和标记,
蛋白质化学技术,以确定光反应性脂肪醇及其类似物的结合位点,
从牛脑洗涤剂提取物中分离的GABAARS中的依托咪酯、丙泊酚和巴比妥类药物,
在培养的细胞中,在从培养的细胞分离的神经元α 4 β 2 AcChoRs中,以及在培养的细胞中的肌肉型AcChoRs中,
从电鳐的电器官中分离出烟碱突触后膜。我们将决定是否一个单一的
GABAAR(或AcChoR)中的麻醉剂结合位点可以被药物占据,根据结构,
作为增效剂或抑制剂。这些光亲和标记研究利用合成化学,
蛋白质化学和蛋白质生产核心。我们的结构研究是对时间的补充-
解决了(米勒/Raines项目)和突变分析(Forman项目)中的光标记研究
旨在确定我们识别的位点是否是功能增强或抑制的位点。
相关性(参见说明):
脑中的GABA受体是许多临床使用的不同化学物质的麻醉剂的主要作用部位
结构,但在GABAARS或结构中的麻醉剂结合位点的数量和位置
相关的烟碱乙酰胆碱受体仍然未知。确定这些地点将有助于
开发具有更高选择性和更少副作用的麻醉剂。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
JONATHAN Brewer COHEN其他文献
JONATHAN Brewer COHEN的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('JONATHAN Brewer COHEN', 18)}}的其他基金
Project 1: Locating General Anesthetic Binding Sites in GABAA & Acetylcholine Rec
项目 1:定位 GABAA 中的全身麻醉结合位点
- 批准号:
8137268 - 财政年份:2010
- 资助金额:
$ 29.7万 - 项目类别:
LOCATING GENERAL ANESTHETIC SITES IN ACETYCHOLINE RECEPTORS
定位乙酰胆碱受体中的一般麻醉部位
- 批准号:
6564606 - 财政年份:2001
- 资助金额:
$ 29.7万 - 项目类别:
LOCATING GENERAL ANESTHETIC SITES IN ACETYCHOLINE RECEPTORS
定位乙酰胆碱受体中的一般麻醉部位
- 批准号:
6410441 - 财政年份:2000
- 资助金额:
$ 29.7万 - 项目类别:
LOCATING GENERAL ANESTHETIC SITES IN ACETYCHOLINE RECEPTORS
定位乙酰胆碱受体中的一般麻醉部位
- 批准号:
6443400 - 财政年份:2000
- 资助金额:
$ 29.7万 - 项目类别:
LOCATING GENERAL ANESTHETIC SITES IN ACETYCHOLINE RECEPTORS
定位乙酰胆碱受体中的一般麻醉部位
- 批准号:
6204345 - 财政年份:1999
- 资助金额:
$ 29.7万 - 项目类别:
相似海外基金
Unraveling Adverse Effects of Checkpoint Inhibitors Using iPSC-derived Cardiac Organoids
使用 iPSC 衍生的心脏类器官揭示检查点抑制剂的副作用
- 批准号:
10591918 - 财政年份:2023
- 资助金额:
$ 29.7万 - 项目类别:
Optimization of mRNA-LNP vaccine for attenuating adverse effects and analysis of mechanism behind adverse effects
mRNA-LNP疫苗减轻不良反应的优化及不良反应机制分析
- 批准号:
23K15383 - 财政年份:2023
- 资助金额:
$ 29.7万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Elucidation of adverse effects of combined exposure to low-dose chemicals in the living environment on allergic diseases and attempts to reduce allergy
阐明生活环境中低剂量化学品联合暴露对过敏性疾病的不良影响并尝试减少过敏
- 批准号:
23H03556 - 财政年份:2023
- 资助金额:
$ 29.7万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Green tea-based nano-enhancer as an adjuvant for amplified efficacy and reduced adverse effects in anti-angiogenic drug treatments
基于绿茶的纳米增强剂作为抗血管生成药物治疗中增强疗效并减少不良反应的佐剂
- 批准号:
23K17212 - 财政年份:2023
- 资助金额:
$ 29.7万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Effects of Tobacco Heating System on the male reproductive function and towards to the reduce of the adverse effects.
烟草加热系统对男性生殖功能的影响以及减少不利影响。
- 批准号:
22H03519 - 财政年份:2022
- 资助金额:
$ 29.7万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Mitigating the Adverse Effects of Ultrafines in Pressure Filtration of Oil Sands Tailings
减轻油砂尾矿压力过滤中超细粉的不利影响
- 批准号:
563657-2021 - 财政年份:2022
- 资助金额:
$ 29.7万 - 项目类别:
Alliance Grants
1/4-Deciphering Mechanisms of ECT Outcomes and Adverse Effects (DECODE)
1/4-破译ECT结果和不良反应的机制(DECODE)
- 批准号:
10521849 - 财政年份:2022
- 资助金额:
$ 29.7万 - 项目类别:
4/4-Deciphering Mechanisms of ECT Outcomes and Adverse Effects (DECODE)
4/4-破译ECT结果和不良反应的机制(DECODE)
- 批准号:
10671022 - 财政年份:2022
- 资助金额:
$ 29.7万 - 项目类别:
2/4 Deciphering Mechanisms of ECT Outcomes and Adverse Effects (DECODE)
2/4 ECT 结果和不良反应的破译机制(DECODE)
- 批准号:
10670918 - 财政年份:2022
- 资助金额:
$ 29.7万 - 项目类别:
Adverse Effects of Using Laser Diagnostics in High-Speed Compressible Flows
在高速可压缩流中使用激光诊断的不利影响
- 批准号:
RGPIN-2018-04753 - 财政年份:2022
- 资助金额:
$ 29.7万 - 项目类别:
Discovery Grants Program - Individual














{{item.name}}会员




